Scholar Rock appoints Richard Brudnick to Board of Directors

Scholar Rock Holding Corp

Richard Brudnick appointed to Board as independent director effective April 6, 2023.
Board size increased to ten; Brudnick joins Audit Committee; Kristina Burow steps off.
Brudnick is Chief Business Officer of Prime Medicine; previously at Bioverativ and Biogen.
Srinivas Akkaraju appointed to Science, Innovation and Technology Committee.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Richard Brudnick

Director

SRRK · Scholar Rock Holding Corp

Effective: 2023-04-06
Filed: April 10, 2023, 7:59 PM ET

appointed Richard Brudnick to join the Board, effective on April 6, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Brudnick was appointed as Director at Scholar Rock Holding Corp.

Action: appointed
Role: Director

Exact text from the filing

appointed Richard Brudnick to join the Board, effective on April 6, 2023

View on SEC.gov

Scholar Rock Holding Corp filing history →

Source: SEC EDGAR

accession 0001157523-23-000532

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.